TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Today

NL

Article

EBCapitalMarkets published an article 10:05 AM

3 Simple Reasons Doctors May Stick With Gilead Sciences Instead of AbbVie

Gilead Sciences hepatitis C drug Harvoni offers three important advantages over AbbVie's competing hepatitis C drug cocktail.

Yesterday

NL

Article

EBCapitalMarkets published an article 9:23 AM

BioMarin Takes Aim at Sarepta

BioMarin's acquisition of Prosensa puts it in direct competition with Sarepta.

Fri Nov 21

NL

Article

EBCapitalMarkets published an article 5:40 PM

AbbVie Takes Aim at Gilead Sciences

AbbVie has won support from a key advisory committee for its new hepatitis C drug cocktail.

NL

Article

EBCapitalMarkets published an article 11:05 AM

3 Fast-Growing Biotech Stocks To Buy in December

You don't want to miss out on these tiny biotechs expected to see earnings grow sharply in 2015.

Thu Nov 20

NL

Article

EBCapitalMarkets published an article 5:05 PM

This May Be the Fastest Growing Big Biotech Stock Next Year (Hint: It's Not Gilead Sciences)

Analysts expect that Celgene Corporation will deliver greater earnings per share growth than Gilead Sciences in 2015.

NL

Article

EBCapitalMarkets published an article 10:34 AM

Will UnitedHealth Group's Dividend Be Safe?

Affordable Care Act headwinds are weighing on UnitedHealth's profit, but the company appears to be on solid financial footing.

Wed Nov 19

NL

Article

EBCapitalMarkets published an article 7:19 PM

The Crucial Thing You're Missing About Many Dividend Stocks

In this edition of "Where the Money Is," one Motley Fool contributor explains why the earnings payout ratio isn't the ratio dividend investors should actually be watching.

NL

Article

EBCapitalMarkets published an article 5:25 PM

Should Allergan Investors Stick With Actavis?

Just because you own Allergan doesn't mean you should necessarily own Actavis.

Tue Nov 18

NL

Article

EBCapitalMarkets published an article 3:52 PM

Will Bristol-Myers Squibb's Dividend Be Safe?

Bristol-Myers Squibb is battling patent expiration, but some fast-growing new drugs just may be able to save its dividend.

NL

Article

EBCapitalMarkets published an article 1:54 PM

How Much Will Obamacare Cost You?

Uninsured consumers visiting the exchanges will see various prices due to these five reasons.

Mon Nov 17

NL

Article

EBCapitalMarkets published an article 1:12 PM

Who Doesn't Have to Pay the Obamacare Penalty?

The Affordable Care Act includes penalties for those who don't have health insurance, but some people may be exempt.

NL

Article

EBCapitalMarkets published an article 10:09 AM

Is This 3D Systems' Future?

Healthcare offers major opportunity for 3-D printing companies including 3D Systems.

Fri Nov 14

NL

Article

EBCapitalMarkets published an article 3:46 PM

Will Pfizer's Dividend Be Safe?

Pfizer is facing stiff headwinds tied to patent expiration, but its dividend appears to remain rock solid.

Thu Nov 13

NL

Article

EBCapitalMarkets published an article 5:50 PM

How Big Is the Penalty for Not Having Health Insurance?

Uninsured Americans will pay a stiff penalty for choosing not to have health insurance this year.

NL

Article

EBCapitalMarkets published an article 10:27 AM

What Consumers Need to Know About Obamacare Open Enrollment

The basics consumers should know before selecting a plan on the healthcare insurance exchanges.

Tue Nov 11

NL

Article

EBCapitalMarkets published an article 4:57 PM

Bill Ackman's Latest Target: Zoetis Inc.

Bill Ackman's latest investment is in Zoetis, an animal health business with more than $4 billion in annual sales.

NL

Article

EBCapitalMarkets published an article 2:56 PM

Another Good Reason to Buy This Marijuana Stock?

Insys' third-quarter results suggest the company has the resources necessary to advance its medical marijuana programs through trials.

NL

Article

EBCapitalMarkets published an article 12:30 PM

Why Novartis and Regeneron Care About This Tiny Biotech Stock

Ophthotech's Fovista may tip the scale in favor of either Novartis' Lucentis or Regeneron's Eylea.

NL

Article

EBCapitalMarkets published an article 9:53 AM

Preventing Ebola? These 3 Healthcare Stocks Are Working On It

Halyard Health, Cantel Medical, and Stericycle offer infection control products that should see demand growth for years to come.

Mon Nov 10

NL

Article

EBCapitalMarkets published an article 7:41 PM

This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success

Achillion Pharmaceuticals is working on an adjunct therapy that could significantly reduce the number of weeks hepatitis C patients would require treatment.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 34.83
Player Rank 48924 out of 75066
Score -62.27
Score Change Today -0.29
Accuracy 38.24%
Active Picks 34
Total Picks 34
Best Pick MDVN (+63.90)
Worst Pick URBN (-46.46)
Average Score per Pick -1.83
Charms Earned 5
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts